---
schema_version: "secwatch.filing_event.v1"
accession: "0000927066-23-000175"
form_type: "8-K"
ticker: "DVA"
cik: "0000927066"
company_name: "DAVITA INC."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T10:46:19.559628+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DaVita reports Q2 2023 revenue of $3.0B; diluted EPS $1.91, adjusted EPS $2.08

## Summary
- Consolidated revenue $3.0B; operating income $405M; adjusted operating income $432M.
- Diluted GAAP EPS $1.91; adjusted diluted EPS $2.08; free cash flow $260M.
- Refinanced existing term loan and revolver with new $1.25B Term Loan A-1 and $1.5B revolver.
- Six-month net income $294M vs $387M in prior year, a 24% decline.
- CEO highlights strong clinical innovation and operational improvements; reaffirms full-year outlook.

## SEC filing metadata
- accession: 0000927066-23-000175
- form_type: 8-K
- ticker: DVA
- cik: 0000927066
- company_name: DAVITA INC.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927066/000092706623000175/0000927066-23-000175-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927066/000092706623000175/dva-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927066-23-000175
- JSON: https://secwatch.observer/filing/0000927066-23-000175.json
- Plain text: https://secwatch.observer/filing/0000927066-23-000175.txt

## Key facts
- Earnings Releases
  DAVITA INC. reported the quarter ended June 30, 2023 results: revenue $3.0 billion, net income $179 million, EPS $1.91.
  - Period: the quarter ended June 30, 2023
  - Revenue: $3.0 billion
  - Net income: $179 million
  - EPS: $1.91
  - Result: reported results
  source text: to deliver strong clinical outcomes and financial results for the year." Financial and operating highlights for the quarter ended June 30, 2023: • Consolidated revenues were $3.0 billion. • Operating income was $405 million and adjusted operating income was $432 million. • Diluted earnings per share was $1.91 and adjusted diluted earnings per share was $2.08. •
  evidence_url: https://www.sec.gov/Archives/edgar/data/927066/000092706623000175/0000927066-23-000175-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.